Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Onconova Therapeutic (NQ: ONTX )

1.540 USD +0.060 (+4.05%)
Official Closing Price Updated: 7:59 PM EST, Feb 24, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Onconova Therapeutic

< Previous 1 2 3 4 5 6 Next >
Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement
From GlobeNewswire News Releases
Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients
- Financialnewsmedia.com News Commentary 
From PR Newswire
Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option
From GlobeNewswire News Releases
Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference
From GlobeNewswire News Releases
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
From GlobeNewswire News Releases
Onconova Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
From GlobeNewswire News Releases
Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $12 Billion By 2027
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $12 Billion By 2027
Financialnewsmedia.com News Commentary 
From PR Newswire
Onconova Therapeutics, Inc. to Present at NobleCon17 Virtual Event
From GlobeNewswire News Releases
Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering
From GlobeNewswire News Releases
Thinking about buying stock in Sundial Growers, BioNano Genomics, Zomedica, Jaguar Health, or Onconova Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, BNGO, ZOM, JAGX, and ONTX. 
From PR Newswire
Thinking about buying stock in Onconova Therapeutics, Jaguar Health, Acasti Pharma, Zomedica, or Riot Blockchain?
InvestorsObserver issues critical PriceWatch Alerts for ONTX, JAGX, ACST, ZOM, and RIOT. 
From PR Newswire
Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
Company affirms plans to begin enrollment of patients with HR+ HER2- metastatic breast cancer and other tumors in U.S. Phase 1 trial in the first half of 2021 
From GlobeNewswire News Releases
Advanced Testing Options Help Alter the Fight Against Cancer
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about buying stock in Sundial Growers, Zomedica, Advanced Micro Devices, Jaguar Health, or Onconova Therapeutics?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, ZOM, AMD, JAGX, and ONTX. 
From PR Newswire
Thinking about buying stock in Jaguar Health, Zomedica, Sundial Growers, Onconova Therapeutics, or Transocean?
InvestorsObserver issues critical PriceWatch Alerts for JAGX, ZOM, SNDL, ONTX, and RIG. 
From PR Newswire
Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
From GlobeNewswire News Releases
Innovative Software Solutions Arise for a Returning Workforce
FinancialBuzz.com News Commentary 
From PR Newswire
Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Onconova Therapeutics to Provide Corporate Update and Third Quarter 2020 Financial Results on November 12, 2020
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Thursday, November 12 
From GlobeNewswire News Releases
Onconova Therapeutics to Present Update During the 2020 BIO Investor Forum Digital Event
From GlobeNewswire News Releases
Thinking about buying stock in Onconova Therapeutics, Norwegian Cruise Line, Ampio Pharmaceuticals, Delta Air Lines, or Plug Power?
InvestorsObserver issues critical PriceWatch Alerts for ONTX, NCLH, AMPE, DAL, and PLUG. 
From PR Newswire
Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals
From GlobeNewswire News Releases
Innovative Diagnostic Techniques are in Demand as Social Distancing Rules Ease
FinancialBuzz.com News Commentary 
From PR Newswire
Onconova Therapeutics Announces Participation at Upcoming Virtual Events
From GlobeNewswire News Releases
Onconova Therapeutics Announces Election of James J. Marino, JD, MBA as Chairman of the Board of Directors
Onconova remains focused on development of its proprietary pipeline of targeted agents as it enters a new phase as a biopharmaceutical company 
From GlobeNewswire News Releases
Onconova Therapeutics Announces Topline Results from the Pivotal Phase 3 INSPIRE Trial
From GlobeNewswire News Releases
Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020
Company to host conference call and webcast at 4:30 p.m. Eastern Time on Wednesday, August 12 
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.